Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Share-based Compensation (2017 - 2026)

Cogent Biosciences' Share-based Compensation history spans 10 years, with the latest figure at $16.9 million for Q1 2026.

  • Quarterly Share-based Compensation rose 68.94% to $16.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $38.3 million through Mar 2026, down 5.02% year-over-year, with the annual reading at $46.1 million for FY2025, 15.95% up from the prior year.
  • Share-based Compensation came in at $16.9 million for Q1 2026, up from $1.1 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $16.9 million in Q1 2026 to a low of $1.1 million in Q4 2025.
  • The 5-year median for Share-based Compensation is $8.9 million (2023), against an average of $8.1 million.
  • Year-over-year, Share-based Compensation surged 134.42% in 2022 and then crashed 88.97% in 2025.
  • Cogent Biosciences' Share-based Compensation stood at $5.0 million in 2022, then surged by 75.72% to $8.9 million in 2023, then grew by 12.72% to $10.0 million in 2024, then tumbled by 88.97% to $1.1 million in 2025, then surged by 1437.09% to $16.9 million in 2026.
  • Per Business Quant, the three most recent readings for COGT's Share-based Compensation are $16.9 million (Q1 2026), $1.1 million (Q4 2025), and $10.6 million (Q3 2025).